---
title: A study to compare the absorption of two tablet strengths with the absorption of a solution.
euct_id: 2024-519835-41-00
phase: Phase 2
status: Completed
sponsor: Arvinas Operations Inc.
canonical_url: "https://parkinsonspathways.com/trials/eu/2024-519835-41-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2024-519835-41-00"
ctis_last_updated: "2025-07-18T03:31:03.427574578"
source: EU Clinical Trials Information System (CTIS)
---
# A study to compare the absorption of two tablet strengths with the absorption of a solution.

**EU CT Number:** [2024-519835-41-00](https://euclinicaltrials.eu/ctis-public/view/2024-519835-41-00)

## Key Facts

- **Phase:** Phase 2
- **Status:** Completed
- **Sponsor:** Arvinas Operations Inc.
- **Start Date:** 2025-03-10
- **Completion Date:** 2025-06-30
- **Conditions:** Parkinson's Disease

## Member States

Trial is authorized in 1 member state: Netherlands.

## Sites (1)

- Centre for Human Drug Research, Leiden, Netherlands

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Maximum age:** 64 Years
- **Sex:** ALL

```
Condition: Parkinson's Disease
Age groups: adults 18-64
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2024-519835-41-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2024-519835-41-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2024-519835-41-00*